New York City :: NY :: USA
| updated Fri Oct 02 10:03:35 -0700 2009
| health-news
U.S. researchers say they are testing gammaglobulin as a treatment to help slow the progress of Alzheimer's disease. The study -- called the Gammaglobulin Alzheimer's Partnership Study -- is recruiting 360 participants at 36 sites nationwide. The large Phase III...
This report's viewers come from the following
country:
United States of America (100.0%)
Loading News...
Loading Twitter credential form...
Loading Twitter complete screen...
This beta report credibility rating is intended to help our community sort through uncensored citizen media reports. For more information, see the Report Credibility section in our FAQ
Loading activation form...
Loading login form...
Loading sign up form...
Loading activation form...
Loading password form...
Loading new incentive enroll form...
Loading invite contacts form...
Invite your friends
Please enter an optional message below, check the friends you want to invite, hit "Send Invitation," and you're done!